Back
Status filter :


RESET SEARCH AND FILTERS
Blood and blood-forming organs
Blood and blood-forming organs / Hypoplastic, haemolytic, and renal anaemias
  eltrombopag On Formulary NICE TA293
  Tablet
Revolade (Novartis Pharmaceuticals UK Ltd) On Formulary
Blood and blood-forming organs / Sickle-cell disease
  hydroxycarbamide On Formulary
  Capsule
Hydroxycarbamide (Non-proprietary) On Formulary
Blood and blood-forming organs / Iron deficiency anaemia
  ferrous fumarate On Formulary
  ferrous gluconate On Formulary
  Tablet
Ferrous gluconate (Non-proprietary) On Formulary
  ferrous sulfate On Formulary
  Tablet
Ferrous sulfate (Non-proprietary) On Formulary
  Modified-release tablet
Ferrograd (Teofarma S.r.l.) On Formulary
  ferrous sulfate with ascorbic acid On Formulary
  Modified-release tablet
Ferrograd C (Teofarma S.r.l.) On Formulary
  iron dextran On Formulary
  Solution for injection
CosmoFer (Pharmacosmos UK Ltd) On Formulary
  sodium feredetate On Formulary
Blood and blood-forming organs / Megaloblastic anaemia
  cyanocobalamin On Formulary
Vitamin B12 Replacement Guidances

BSH guidance on Vit B12 replacement during COVID

 

Non-dietary vitamin B12 deficiency

  • NICE 2019 RECOMMENDATION:

        Administer hydroxocobalamin 1mg intramuscularly every 2-3 months for life.

  • BHS advice during the COVID-19 pandemic for patients established on intramuscular hydroxocobalamin

        The need for IM hydroxocobalamin should be discussed with each patient individually.

        As an alternative, oral cyanocobalamin can be offered at a dose of 1mg per day until regular IM

        hydrocobalamin can be resumed.

 

Diet related B12 deficiency 

  • NICE 2019 RECOMMENDATION & BSH advice during COVID-19 pandemic:

        Advice peopl either to take oral cyanocobalamin tablets 50 -150 microgram daily between meals or have a twice-yearly hydroxocobalamin 1mg IM injection.

Vitamin B12 Replacement Guidances

BSH guidance on Vit B12 replacement during COVID

 

Non-dietary vitamin B12 deficiency

  • NICE 2019 RECOMMENDATION: Administer hydroxocobalamin 1mg intramuscularly every 2-3 months for life.
  • BHS advice during the COVID-19 pandemic for patients established on intramuscular hydroxocobalamin: The need for IM hydroxocobalamin should be discussed with each patient individually. As an alternative, oral cyanocobalamin can be offered at a dose of 1mg per day until regular IM hydrocobalamin can be resumed.

 

Diet related B12 deficiency 

  • NICE 2019 RECOMMENDATION & BSH advice during COVID-19 pandemic: Advice peopl either to take oral cyanocobalamin tablets 50 -150 microgram daily between meals or have a twice-yearly hydroxocobalamin 1mg IM injection.

  folic acid On Formulary
  hydroxocobalamin On Formulary
Blood and blood-forming organs / Iron overload
  deferasirox On Formulary
  Tablet
Exjade (Novartis Pharmaceuticals UK Ltd) On Formulary
  desferrioxamine mesilate On Formulary
  Powder for solution for injection
Desferrioxamine mesilate (Non-proprietary) On Formulary
Desferal (Novartis Pharmaceuticals UK Ltd) On Formulary
Blood and blood-forming organs / Neutropenia
  filgrastim On Formulary
  Solution for injection
Zarzio (Sandoz Ltd) On Formulary
  lenograstim Off Formulary
  Powder and solvent for solution for injection
Granocyte (Chugai Pharma UK Ltd) On Formulary
Blood and blood-forming organs / Essential thrombocythaemia
  anagrelide On Formulary
  Capsule
Anagrelide (Non-proprietary) On Formulary
Xagrid (Takeda UK Ltd) On Formulary
  hydroxycarbamide On Formulary
  Capsule
Hydroxycarbamide (Non-proprietary) On Formulary